We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
AUM
$3.36B
AUM Growth
+$82M
Cap. Flow
+$65.6M
Cap. Flow %
1.95%
Top 10 Hldgs %
33.03%
Holding
318
New
25
Increased
113
Reduced
72
Closed
11

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$22.7M
2
BURL icon
Burlington
BURL
+$14.9M
3
PRCT icon
Procept Biorobotics
PRCT
+$13.9M
4
DELL icon
Dell
DELL
+$10.2M
5
ASML icon
ASML
ASML
+$7.37M

Top Sells

Rank Stock Value
1
DV icon
DoubleVerify
DV
+$45.6M
2
PGR icon
Progressive
PGR
+$16.3M
3
TDC icon
Teradata
TDC
+$14.4M
4
NFLX icon
Netflix
NFLX
+$13.1M
5
TMO icon
Thermo Fisher Scientific
TMO
+$7.45M

Sector Composition

Rank Sector Weight
1 Technology 31.04%
2 Healthcare 18.24%
3 Communication Services 14.1%
4 Financials 12.02%
5 Consumer Discretionary 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVMI
151
Nova
NVMI
$12.4B
$1.17M 0.03%
5,000
DIS icon
152
Walt Disney
DIS
$167B
$1.17M 0.03%
11,808
+1,277
+12% +$137K
SMCI icon
153
Super Micro Computer
SMCI
$18.4B
$1.16M 0.03%
14,110
VZ icon
154
Verizon
VZ
$195B
$1.14M 0.03%
27,551
+27
+0.1% +$1.09K
ITOT icon
155
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
$1.12M 0.03%
9,418
NTRS icon
156
Northern Trust
NTRS
$22.4B
$1.11M 0.03%
13,252
+2,315
+21% +$194K
IDEV icon
157
iShares Core MSCI International Developed Markets ETF
IDEV
$31.7B
$1.11M 0.03%
+16,856
New +$1.12M
ELV icon
158
Elevance Health
ELV
$81.5B
$1.1M 0.03%
2,036
-4,336
-68% -$2.29M
MAR icon
159
Marriott International
MAR
$98.3B
$1.1M 0.03%
4,543
TJX icon
160
TJX Companies
TJX
$174B
$1.1M 0.03%
9,975
+65
+0.7% +$6.55K
CHE icon
161
Chemed
CHE
$7.07B
$1.09M 0.03%
2,000
SCHW
162
Charles Schwab
SCHW
$183B
$1.07M 0.03%
+14,557
New +$1.08M
BP icon
163
BP
BP
$116B
$1.07M 0.03%
29,527
LH icon
164
Labcorp
LH
$25.4B
$1.03M 0.03%
+5,054
New +$1.03M
ABNB icon
165
Airbnb
ABNB
$89.9B
$1.02M 0.03%
6,734
DUK icon
166
Duke Energy
DUK
$97.8B
$1.01M 0.03%
10,070
IT icon
167
Gartner
IT
$10.1B
$988K 0.03%
2,200
EPD icon
168
Enterprise Products Partners
EPD
$82.3B
$986K 0.03%
34,018
ADI icon
169
Analog Devices
ADI
$179B
$983K 0.03%
4,305
APD icon
170
Air Products & Chemicals
APD
$65.7B
$975K 0.03%
3,780
-273
-7% -$69.2K
CYBR
171
DELISTED
CyberArk
CYBR
$971K 0.03%
3,550
+712
+25% +$175K
NKE icon
172
Nike
NKE
$61.9B
$957K 0.03%
12,693
+3,000
+31% +$279K
IWF icon
173
iShares Russell 1000 Growth ETF
IWF
$121B
$954K 0.03%
10,468
-272
-3% -$23.2K
DE icon
174
Deere & Co
DE
$160B
$930K 0.03%
2,490
+500
+25% +$195K
LECO icon
175
Lincoln Electric
LECO
$14.3B
$914K 0.03%
4,843
-4,742
-49% -$1.03M

Similar funds

Chicago Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Chicago Capital held 318 positions worth $3.36B, up 2.5% from $3.28B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Chicago Capital's Q2 2024 filing shows 25 new, 113 increased, 72 reduced and 11 closed positions. Its largest new stake was Procept Biorobotics: 232,983 shares worth $14.2M. The largest sale was DoubleVerify, an estimated $45.6M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Communication Services.

  • Chicago Capital's largest Q2 2024 buy was Procept Biorobotics: 232,983 shares worth $14.2M.
  • Chicago Capital added most to Ligand Pharmaceuticals in Q2 2024, an estimated $22.7M increase.
  • Chicago Capital's biggest Q2 2024 reduction was DoubleVerify, cutting an estimated $45.6M.
  • Chicago Capital fully exited lululemon athletica in Q2 2024, selling an estimated $4.4M.
  • Chicago Capital's ten largest holdings make up 33% of its $3.36B portfolio in Q2 2024.
  • Chicago Capital opened 25 new positions and closed 11 in Q2 2024.
  • Chicago Capital's portfolio value rose 2.5% quarter-over-quarter to $3.36B.

Based on Chicago Capital's 13F filing for Q2 2024, filed 6 Aug 2024.